In the summer of 2012, Stryker issued a voluntary product recall for both the Rejuvenate and the ABG II implants, stating the metal components could rub against one another, causing fretting and corrosion that could lead to side effects like tissue damage and death, inflammation,…
Those at the Endocrine Society believe “large scale, prospective, randomized controlled trials” are needed to decide what the risks and benefits are associated with testosterone therapy treatment. Specifically, the Endocrine Society wants trials involving older men who are experiencing a natural de
Stephani Victor, spokesperson for the Chaffin Luhana Foundation and Paralympic downhill skier, is headed for the Sochi 2014 Paralympic Winter Games. This year, NBC will be offering an unprecedented 52 hours of coverage of the events, allowing viewers to follow these impressive athletes. A traumatic…
The FDA is investigating the risk of heart attack, stroke and death among men taking different forms of testosterone therapy. This announcement came after two recent studies, one published in PLOS One, and the other in the Journal of the American Medical Association (JAMA). History…
News of the FDA investigating the risk of heart attack, stroke and death in men taking testosterone therapy treatments appears to already be having an impact on the sale of the company’s stock, and not just in the United States. In an article published in…
Some patients who received St. Jude Eon Mini implant surgery have complained about reduced pain relief, a return of symptoms, suffered from burns, or needed the device removed after surgery. The FDA issued recalls after learning of potential issues with the Eon Mini battery and…
On February 4, 2014, Johnson & Johnson and Ethicon were ordered by a judge to pay for not preserving evidence in In re Ethicon, Inc. Pelvic Repair Systems Product Liability Litigation. This litigation comes after the U.S. Food and Drug Administration received reports from hundreds…
On February 4, 2014, five lawsuits were filed in Illinois federal court against AbbVie Inc., and Abbott Laboratories, Inc., the manufacturers of Androgel, a testosterone therapy treatment. This Androgel lawsuit comes just days after the U.S. Food and Drug Administration (FDA) announced that it is…
In April 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Mirena lawsuits into one court in the Southern District of New York. About a month later, the Supreme Court of New Jersey also centralized state Mirena lawsuits into one court in…
In the summer of 2012, Stryker implemented a voluntary recall of the Rejuvenate and ABG II hip replacement systems. They stated the devices presented “potential risks associated with modular-neck stems” that could lead to pain, swelling, tissue reactions, and premature hip implant failure. Since the
Boehringer Ingelheim, the manufacturer of blood-thinning drug Pradaxa, was recently fined nearly $1 million because it allegedly lost and destroyed important files. District Judge David Herndon, who is overseeing the coordinated Pradaxa lawsuits currently proceeding in the Southern District of Illin
Is testosterone therapy more of a benefit or risk for male patients? It’s a question once again under the microscope after a 2014 PLOS One study looked at the risk of acute non-fatal myocardial infarction (MI) after men were prescribed a form of testosterone therapy. …
